Abstract Background Cell cycle dysregulation is common in human malignancies. and CDK4/6 inhibitors targeting cell cycle have potential antitumor activity. SHR6390 is a novel small molecule inhibitor specifically targeting the CDK4/6 pathway. However. https://www.roneverhart.com/Western-Digital-Re-WD6001FSYZ-6TB-7-2K-RPM-SATA-6Gb-s-128MB-3-5-Hard-Drive/